About Dexcom
Dexcom is a company based in San Diego (United States) founded in 1999.. Dexcom has raised $52.5 million across 8 funding rounds from investors including HHS, Warburg Pincus and Canaan. The company has 10,300 employees as of December 31, 2024. Dexcom has completed 2 acquisitions, including SweetSpot Diabetes and TypeZero Technologies. Dexcom offers products and services including Dexcom G7 and Dexcom App. Dexcom operates in a competitive market with competitors including Livongo, Senseonics, One Drop, mySugr and Jana Care, among others.
- Headquarter San Diego, United States
- Employees 10300 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dexcom, Inc.
-
Annual Revenue
$4.03 B11.34as on Dec 31, 2024
-
Net Profit
$576.2 M6.41as on Dec 31, 2024
-
EBITDA
$817.7 M4.34as on Dec 31, 2024
-
Total Equity Funding
$52.5 M (USD)
in 8 rounds
-
Latest Funding Round
$1.05 B (USD), Post-IPO
Apr 11, 2020
-
Investors
HHS
& 4 more
-
Employee Count
10300
as on Dec 31, 2024
-
Investments & Acquisitions
SweetSpot Diabetes
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Dexcom
Dexcom is a publicly listed company on the NASDAQ with ticker symbol DXCM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Dexcom
Dexcom offers a comprehensive portfolio of products and services, including Dexcom G7 and Dexcom App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Real-time glucose monitoring device that reduces fingerstick needs.
App for viewing glucose data on smartphones and smartwatches.
Unlock access to complete
Unlock access to complete
Software Development Team
241 people
Leadership Team
61 people
Product Management Team
60 people
Senior Team
46 people
Sales and Marketing
42 people
Human Resources and Administration
31 people
Staff Team
28 people
Finance and Accounting
25 people
Unlock access to complete
Funding Insights of Dexcom
Dexcom has successfully raised a total of $52.5M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.05 billion completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $1.1B
-
First Round
First Round
(03 Jun 2002)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Post-IPO - Dexcom | Valuation |
investors |
|
| Dec, 2018 | Amount | Post-IPO - Dexcom | Valuation |
investors |
|
| May, 2016 | Amount | Post-IPO - Dexcom | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dexcom
Dexcom has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Warburg Pincus and Canaan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in US life-sciences and tech companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dexcom
Dexcom has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SweetSpot Diabetes and TypeZero Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Device for continuous glucose monitoring with manually operated insulin delivery
|
2013 | ||||
|
Platform to aggregate and analyze blood glucose data from devices
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Dexcom
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dexcom Comparisons
Competitors of Dexcom
Dexcom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Livongo, Senseonics, One Drop, mySugr and Jana Care, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dexcom
Frequently Asked Questions about Dexcom
When was Dexcom founded?
Dexcom was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Where is Dexcom located?
Dexcom is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Dexcom?
Kevin Sayer is the current CEO of Dexcom.
Is Dexcom a funded company?
Dexcom is a funded company, having raised a total of $52.5M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $7.23M, raised on Jun 03, 2002.
How many employees does Dexcom have?
As of Dec 31, 2024, the latest employee count at Dexcom is 10,300.
What is the annual revenue of Dexcom?
Annual revenue of Dexcom is $4.03B as on Dec 31, 2024.
What does Dexcom do?
Dexcom was founded in 1999 in San Diego, United States, and operates in the medical device sector focused on diabetes management. A wearable patch is offered that measures glucose levels continuously, with data transmitted wirelessly to a receiver or display device for real-time viewing. In 2022, revenues reached 3.02 billion, while net profit was recorded at 0.29 billion. The companys products support ongoing monitoring without frequent finger pricks.
Who are the top competitors of Dexcom?
Dexcom's top competitors include Senseonics, One Drop and Livongo.
What products or services does Dexcom offer?
Dexcom offers Dexcom G7 and Dexcom App.
Is Dexcom publicly traded?
Yes, Dexcom is publicly traded on NASDAQ under the ticker symbol DXCM.
How many acquisitions has Dexcom made?
Dexcom has made 2 acquisitions, including SweetSpot Diabetes, and TypeZero Technologies.
Who are Dexcom's investors?
Dexcom has 5 investors. Key investors include HHS, Warburg Pincus, Canaan, Invesco Mutual Fund, and RWI Ventures.
What is Dexcom's ticker symbol?
The ticker symbol of Dexcom is DXCM on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.